Climb Bio CFO Exercises $4.20 Stock‑Option Grant, Signals Confidence in Mid‑Term Growth
Climb Bio CFO’s 142,500‑share option exercise signals executive confidence in mid‑term growth—watch upcoming clinical milestones and insider moves for investment insight.
3 minutes to read